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Abstract 
Orthognathic surgery may be complicated by difficulty in achieving hemostasis because unlike soft tissue, 
the vessels traversing bone cannot be identified and isolated before osteotomy. In this study we evaluated 
the amount of blood loss and duration of surgery under deliberate hypotensive anesthesia in comparison to 
amount of blood loss and duration of surgery under normotensive anesthesia on patients undergoing 
orthognathic surgical procedures. A total of 16 cases undergoing orthognathic surgery were included in this 
clinical study. Patients were randomly grouped under normotensive (group I) or hypotensive group (group 2). 
Patients in hypotensive anesthesia group were given Esmolol to maintain mean arterial pressure in the 
range of 70-80 mm of Hg till osteotomy segments were fixed. There was more than 40% reduction in 
blood loss in orthognathic surgical procedures when induced hypotension was used, but there was not 
statistically significant (p=0.91) reduction in the operative time. Based on surgeons and anesthetist’s 
assessment fast acting agents like Esmolol can be used intraoperatively to induce hypotension as and when 
required.   
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Introduction 
Orthognathic surgeries are frequently performed 
to correct dentofacial deformities stemming from 
hereditary and acquired causes. Although the 
procedure performed is standardized and yields 
predictable results, it is associated with considerable 
blood loss. In these surgeries bleeding occurs from 
soft tissue, intrabony capillaries and vessels. 
Although several methods directly limit the inflow of 
blood to the operative site; the predictability and 
relative safety associated with execution of induced 
hypotension makes it a widely recommended 
method for controlling blood loss in orthognathic 
surgeries (1). Controlled hypotension was first 
proposed by Cushing in 1917 and it developed to 
be an acceptable method. Induced hypotension is 
defined as “a reduction of the systolic blood 
pressure to 80–90 mm of Hg, a reduction of mean 
arterial pressure (MAP) to 50–65 mm of Hg or a 
30% reduction of baseline MAP” (2). Controlled 
hypotension not only reduces blood loss, but also 
improves the surgical field and decreases operative 
time (3), and may obviate the need for blood 
transfusion. This can avoid potential risk of 
transfusion reactions or transmission of blood 
borne pathogens, which are significant factors when 
considering elective procedures like orthognathic 
surgeries (3). Careful selection of agents limits  
the major risks, risks that are generally less 
important than those of transfusion or alternatives 
to transfusion (4). 
Hypotensive agents used successfully alone 
include inhalation anesthetics like Isoflurane, Sodium 
nitroprusside, Nitroglycerin, Trimethaphan, 
Camsilate, Alprostadil, Adenosine, Remifentanil 
and agents used in spinal anesthesia. Agents that 
can be used alone or in combination include 
calcium channel antagonists (e.g. Nicardipine), 
adrenoceptor antagonists [e.g. Propranolol, 
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Hypothesis and Objectives 
The study hypothesis was “If blood loss and 
operating time can significantly reduce in 
orthognathic surgery when hypotensive anesthesia 
using Esmolol is adopted”. 
The objectives of the study were: 
1. To evaluate the amount of blood loss between 
normotensive and hypotensive groups in 
orthognathic surgical procedures.  
2. Duration of surgery under hypotensive anaesthesia 
using Esmolol as hypotensive agent when 
compared to normotensive anesthesia in 
orthognathic procedures. 
Methodology 
A total of 16 cases undergoing orthognathic 
surgery were included in this clinical study. These 
patients underwent standard orthognathic surgical 
procedures. Consent was obtained from institutional 
ethical committee, the patient and respective 
guardians or relatives. 
Data included age, sex, chief complaint, medical 
and dental history, clinical findings, radiographic 
findings, cephalometric findings, blood investigations 
including pre and post-operative hemoglobin, 
hematocrit,  pre and post-operative blood pressure 
(B.P.) records, blood loss during surgery and 
duration of surgery. 
Inclusion Criteria 
Young and healthy adults who were fit under the 
category of American Society of Anesthesiologists, 
Physical Status I (ASA-I) undergoing orthognathic 
surgery. 
Exclusion Criteria 
Patients not fulfilling ASA I criteria e.g.  
cardiovascular, renal and hepatic disorders, 
uncontrolled hypertension, myocardial infarction 
within 6 months, hypovolemia, previous cerebro 
vascular  accidents and pregnancy. 
Diagnosis was made from clinical, radiographic 
and cephalometric findings. Treatment was planned 
giving prime importance to patient's concern. 
Surgeries included single jaw osteotomies and 
double jaw osteotomies. Patients were randomly 
allotted to normotensive (group I) or hypotensive 
group (group II).  Baseline blood pressure was 
recorded in the wards, before the day of surgery, 
in the morning prior to surgery and in operation 
theatre before administering general anesthesia. 
The mean was then calculated.  
Method 
Premedication comprised of oral Diazepam 
and Ranitidine. Anesthesia was induced by 
Thiopentone/Propofol (mixed to Glycopyrrolate) 
and Succinylcholine intravenously. Anesthesia was 
maintained by Halothane and mixture of N2O and 
O2 (60:40 ratios). Long acting muscle relaxant 
(Pancuronium) was given when indicated. 
Head end was kept elevated. 2% Lignocaine 
hydrochloride (2% Xylocaine ® DENTAL) with 
1:80000 Adrenaline was infiltrated before making 
incision in all cases. Patient on hypotensive anesthesia 
were given Esmolol (ESOCARD, Samarth Pharma 
Pvt. Ltd.) 0.5 mg/kg body weight in bolus and 0.1-
0.3 mg/kg intermittently to maintain mean arterial 
pressure in the range of 70-80 mm of Hg till 
osteotomy fragments were fixed (5)   Intermittent 
administration of Esmolol was stopped after the 
last screw was fixed.  Reversal from anesthesia 
was achieved by drugs like Neostigmine and 
Glycopyrrolate. Intravenous infusion of antibiotics 
and steroid (Inj Dexamethasone 8 mg/ Hydrocotisone 
100 mg) were given intra operatively. 
Intraoperative monitoring comprised 
Electrocardiography, blood pressure, pulse oximetry 
and heart rate. Blood pressure was monitored by 
non-invasive method. Oxygen saturation and heart 
rate were continuously monitored using Philips 
SureSigns VS3 Vital Signs Monitor. 
Though invasive blood pressure monitoring is 
considered the gold standard, we have used non-
invasive monitoring. Non-invasive method can be 
used for mild hypotensive procedures (6). 
Duration of anesthesia was calculated from the 
time of induction to reversal. Duration of surgery 
was measured from starting of incision to 
placement of last suture. A provision for single 
observer for measurement of blood loss after every 
surgery was strictly followed. It was measured by 
reducing the amount of saline used from the 
volume of fluid in suction unit. Weight of the dry 
gauze was deducted from weight of blood soaked 
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gauze, 1 gm of weight was considered equivalent 
to 1ml of blood (7). The need to transfuse blood 
perioperative was a combined decision of operating 
surgeon and anesthetist. MAP was gradually raised 
and adequate hemostasis was achieved. 
Statistical analysis was done using student's  
t-test. Differences were considered statistically 
significant when p<0.05. All data are presented as 
mean ± SD. 
Blood loss = A + B 
A = Volume in suction-Volume of saline used 
B = Weight of wet gauze-weight of dry gauze 
Results  
The study group consisted of 16 healthy 
individuals undergoing elective orthognathic surgical 
procedures. They were divided into two groups; 
each consisting of 8 patients. The female, male 
ratio was 6:2 in normotensive group and 7:1 in 
hypotensive group; with an age range of 15 years 
to 28 years in group I and 18 years to 35 years in 
group II (Table 1, Fig. 1).  
Table 1. Demographic Details of Study Groups 
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Fig. 1. Age Distribution of Study Groups 
The mean age in group I and group II was 
found to be 21.75 ± 4.46 years and 23.37 ± 5.88 
years respectively. There was no statistically 
significant difference found between the two 
groups (Table 2, Fig 2). 
Table 2. Comparison between Age of Subjects in 
study Groups 
Study Groups Age (Years) Mean ± SD p* Value Significance 
Normotensive 21.75 ± 4.46 
0.62 NS 
Hypotensive 23.37 ± 5.88 






















Normotensive Hypotensive  
Fig. 2. Mean Weight of Study Groups 
Mean blood loss in group I was 490 ± 441.97 
ml as compared to 393.75 ± 308.12 ml in group II. 
The difference in amount of blood loss was not 
statistically significant. The duration of surgery in 
group I was 238.12 ± 97.28 min whereas it was 
233.12 ± 76.67 min in group II showing no 
statistical significance (Table 3, Fig 3). 
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Fig. 3.  Mean Blood Loss 
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The baseline mean arterial blood pressure and 
intraoperative mean arterial blood pressure in 
group I was found to be 94.34 ± 4.65 and 93.32 ± 
10.33 mm of Hg respectively. The difference 
between the two values was not significant. 
Whereas the difference between baselines mean 
arterial blood pressures and intraoperative mean 
arterial pressures in group 2 was found to be 
highly significant (Table 4, Fig 4). 
Table 4. Comparison of MAP 
Study 
Groups 
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Fig. 4. Mean Duration of surgery (minutes) 
In LeFort I/LeFort I combined with anterior 
maxillary segmental osteotomy, there was 60% 
reduction in blood loss i.e. from 690 ml to 276.7 ± 
128.6 ml. In BSSO the difference in amount  
of blood loss between both groups was statistically 
significant. There was 40% reduction in amount  
of blood loss in group II as compared to group I  
in patients undergoing bijaw surgery. The  
lone case that underwent anterior maxillary 
segmental combined with mandibular subapical 
osteotomy in group I and group II had  
blood loss of 380 ml and 850 ml respectively 
(Table 5, Fig 5). 
Table 5. Comparison of Study Groups with respect 
to Surgical Procedure 
Procedure 











Le Fort I/Le 
Fort+AMS 690 
276.7 ± 
128.6 60 - - 
BSSO 353.3 ± 23.09 
190 ± 
26.46 46 0.001 
H
S 
Bijaw 1500 900 40 - - 
AMS+MSA 380 850 -123 - - 
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Fig. 5. MAP in Case of Hypotensive group 
In LeFort I / LeFort I combined with anterior 
maxillary segmental osteotomy the mean time 
taken was 270 min in group I as compared to 
213.3 ± 59.65 min in group II. In cases of BSSO 
the mean time taken was 210 ± 15 min and 193.3 
± 38.84 min for group I and group II respectively. 
However the difference in duration of surgery 
between both groups was not found to be 
statistically significant. Similarly the lone case that 
underwent anterior maxillary segmental combined 
with mandibular subapical osteotomy in group I 
and group II had duration of surgery for 225 min 
and 255 min respectively (Table 6, Fig 6). Table 7 
and figure 7 describes correlation between blood 
loss and reduction in MAP in the two groups and it 
was not statistically significant. In group II p value 
was 0.06 which was not statistically significant. 
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Table 6. Duration (Minutes) of Surgery 
Proce-
dure 


















270 213.3 ± 9.65 21 - - 
BSSO 210  ± 15 
193.3 
±38.84 8 0.69 
N
S 
Bijaw 460 390 15 - - 
AMS+ 
MSA 225 255 -13 - - 
* Student's t Test 
Table 7. Correlation between Blood Loss and 
Reduction in MAP 
Study Groups Correlation Coefficient Sig 
Normotensive 0.29 P=0.44 NS 
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Fig. 7. Blood Loss in Case of LeFort I/LeFort 
+ AMS 
Discussion 
Progress in the fields of orthodontics, 
anesthesia and maxillofacial surgery has ensured 
that Orthognathic surgery can be carried out in a 
safe fashion leading to predictably stable results. A 
significant and most frequently complication 
encountered intraoperatively is blood loss(8,)(9).  
It has been assessed that 50% of a surgeon’s time 
and a great deal of nervous energy is spent in 
controlling bleeding (10). Bleeding is the quantity 
of blood that appears in the operative field in a 
given time period and it can be expressed in flow 
‘D’ (volume/unit of time) and is mathematically 
related to the pressure by the relationship, D = P/R, 
where ‘P’ is pressure and ‘R’ represents vascular 
resistance. When P decreases and R remains 
constant or increases (vasoconstriction) the flow D 
decreases. On the other hand when P and R 
(vasodilatation) both decrease, the flow D remains 
constant or varies little (4). 
P’ and ‘R’ are local pressure and local vascular 
resistance at the level of the surgical field and they 
depend on (1) the central blood pressure and its 
regulation. (2) The regulation of the local arteriolar 
vasomotor tone by the sympathetic nervous system. 
(3) The microcirculatory auto regulation of the 
organ (when it exists). 
In certain controlled hypotension techniques, 
the decrease in cardiac output is the determining 
factor in the reduction of blood loss whereas in 
other techniques it is the fall in MAP that determines 
the levels of blood loss. The mechanisms responsible 
for the reduction of intraoperative bleeding depends 
on (1) The technique used (that is the effect of the 
agents used on the heart and the vascular network) 
(2) The mechanisms of regulation that these  
agents antagonize and (3) The counter-regulatory 
mechanisms that they cause, which are intricate 
(4)(11). 
It is unsafe to assume that the response of all 
vascular beds to hypotension and surgical trauma 
is identical because it is well known that blood 
flow to each tissue is governed by neural, 
hormonal and local factors. The few studies 
reported in the field of orthognathic surgery have 
been poorly done and inconclusive (12). 
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Potential benefits attributable to hypotensive 
anesthesia in orthognathic surgeries are: 
1)  Reduced blood loss with a consequent reduction 
in risks associated with blood transfusion. 
2) Improved quality (dryness) of the operative field, 
potentially allowing more accurate dissection 
and improved surgical results  
3)  Reduced operative time.  
4) Reduced postoperative swelling due to decreased 
hematoma formation. 
The risk of tissue hypoxia and the difficulty in 
evaluating this risk are very real, although there 
were no specific complications seen in a large 
series of patients subjected to severe controlled 
hypotension (MAP<50mm of Hg) over a prolonged 
duration (11) The current goal of controlled 
hypotension is to maintain a pressure sufficiently 
low to allow a reduction in bleeding without 
suppressing the microcirculatory auto regulation 
of the vital organs (i.e. brain, heart or kidney). 
Another potential complication in hypotensive 
anesthesia is anuria (13). 
None of the current data indicate that controlled 
hypotension with a MAP between 50 and 65 mm 
of Hg is a risk in young healthy patients (4). 
Patients with treated hypertension did not 
seem to present risks and for this reason it was not 
considered an absolute contraindication for controlled 
hypotension in one study (4)(11). Physical measures 
are used some time alone or in adjuvant to 
pharmacological agents for controlled hypotension. 
In placing the operated area higher than the heart, 
postural maneuvers (e.g. a head-up tilt position in 
ear or maxillofacial surgery) have reduced blood 
pressure in this area and decreased venous 
pressure (13). However, there is a risk of air 
embolism with this technique. The hemodynamic 
effects of artificial ventilation have also been used: 
hyperventilation (by means of hypocapnia) involves 
vasoconstriction and a fall in blood flow; and 
hypoventilation (by means of hypercapnia) induces 
vasodilatation and an increase in blood flow(4). 
The ideal agent to induce controlled hypotension 
does not exist. An ideal one must be easy to 
administer, have short onset time, an effect that 
disappears quickly when administration ceases,  
a fast elimination without toxic metabolites, 
negligible effects on vital organs, and a predictable 
and dose-dependent effect(4). 
Drugs used in controlled hypotension include: 
1. Primary agents successfully used alone, for 
example, inhalation anaesthetics, Sodium 
nitroprusside, Nitroglycerin, Trimethaphan, 
Alprostadil, Adenosine, Remifentanil and 
agents for spinal anaesthesia. 
2.  Agents that can be used alone or as adjuncts to 
decrease the adverse effects of other agents,  
for example, calcium channel antagonists  
(e.g. Nicardipine), β adrenoceptor antagonists 
(β-blockers) [e.g. Propranolol, Esmolol] and 
Fenoldopam. 
3. Secondary agents that are used adjunctively 
with primary agents. For example, ACE 
inhibitors and Clonidine. 
Esmolol lowers arterial blood pressure through 
decrease in cardiac output secondary to the 
negative chronotropic and inotropic effects of  
β1-adrenergic antagonism(5). In addition, it may 
produce direct myocardial depression at very high 
doses (e.g. >500 µg/kg/min). Esmolol provides a 
more stable course of controlled hypotension than 
did sodium nitroprusside, with a slightly lower 
mean arterial pressure and fewer deviations from 
the target arterial blood pressure range(14). 
Haemodynamic stability in this case may result 
from the inhibition of autonomically mediated 
secretion of renin and the attenuation of other 
compensatory hormonal responses known to occur 
during controlled hypotension with Sodium 
nitroprusside or Isoflurane (14).  
β-adrenergic blockade will also prevent reflex 
autonomic increases in heart rate in response to the 
vasodilation produced by Isoflurane. Esmolol has 
a brief duration of action, promotes haemodynamic 
stability, and produces beneficial effects in the 
surgical field and in blood conservation. For these 
reasons, it may be preferred as a primary drug  
for inducing hypotension in healthy patients 
undergoing orthognathic surgery.  In the present 
study, no apparent adverse side effects occurred 
when Esmolol was used. Caution is indicated as 
profound myocardial depression may result from 
its use. Preliminary evidence that Esmolol infusion 
at rates >200 µg/kg/min may be deleterious to 
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total body oxygen balance, although the same may 
also be true for therapeutic doses of SNP(14).  The 
following recommendations are suggested for 
minimizing blood loss and optimizing safety 
during orthognathic surgery(14) :(a) Esmolol may 
be used as a primary hypotensive drug in healthy 
patients; (b) the degree of hypotension should be 
titrated to observed blood loss (extremes of  
hypotension may not be required); (c) when using 
Esmolol alone to produce hypotension as low as 
60 mm of Hg, cardiac output should be monitored; 
and (d) Esmolol should be used in combination with 
other hypotensive drugs to limit the doses required. 
W. Chan, D.E. Smith et al. compared the 
blood loss, quality of operative field and the length 
of surgery in one type of orthognathic surgery i.e. 
anterior maxillary osteotomy in normotensive and 
hypotensive anesthesia. They found that by dropping 
a patient’s operative mean blood pressure by 20% 
or more, the quality of surgical field can be 
significantly improved (27%) and loss of blood 
can be decreased (41%).The difference in length of 
surgery was insignificant(15) Golia J.K, Woo R.  
et al. used Nitroglycerin for controlled hypotension 
in orthognathic surgeries.NTG was used to lower 
mean arterial pressure during periods of potential 
increased blood loss. Estimated blood loss was 
439+/-1.19 ml. (16).Fromme GA, Mackenzie RA 
et al included 56 ASA class I patients requiring 
orthognathic surgery. Mean measure blood loss 
was not statistically significant (17). 
Mc Nultys et al. evaluated the effectiveness of 
Labetalol in producing controlled reduction in 
mean arterial pressure during orthognathic surgery. 
They concluded that labetalol is safe and effective 
alternative for producing controlled hypotension in 
orthognathic surgery. It offers the advantage of 
better preservation of arterial oxygen saturation 
and decreasing myocardial oxygen consumption 
through its β blocking action. In their 10 patients 
mean blood loss was 399 ± 142 ml (18). 
Blau W.S, Kafer E.R et al compared the efficacy 
of Esmolol and Sodium nitroprusside (SNP) as a 
primary drug for producing controlled hypotension 
and limiting blood loss during orthognathic 
surgery. Both infusions were titrated to obtain a 
mean arterial blood pressure within target range of 
55-65 mm of Hg. They found Esmolol to be more 
effective than sodium nitroprusside in reducing 
blood loss. The MAP was 58.7 ± 0.7 and 61.8 ± 
0.4 mm of Hg for Esmolol and SNP respectively. 
The mean blood loss was 436 ± 65 ml. with 
Esmolol and 895 ± 101ml with SNP. The surgical 
field was judged to be significantly (p≤0.05) drier 
with Esmolol than with SNP(14). 
Dolman R M did a prospective study to 
compare quality of surgical field, blood loss  
and operative time with either hypotensive or 
normotensive anesthesia during Lefort I osteotomies. 
It was found that there was a significant correlation 
between (p<0.0001) surgeon’s perception of quality 
of surgical field and the blood pressure. There was 
a statistically significant reduction in blood loss  
(p < 0.01) when using hypotensive anesthesia and no 
significant reduction (p=0.44) in operative time (19). 
Yu CNF conducted a prospective study in 32 
patients under induced hypotensive anesthesia. It 
was found that mean estimated blood loss for 
double jaw surgery was 617.6 ml, mean estimated 
blood loss during Lefort I was half that of multiple 
segmentalised oseotomies. For mandibular ramus 
osteotomies, mean ABL and operating time was 
280 ml and 2 hours respectively, for anterior 
mandibular osteotomies the corresponding values 
were 171.3 ml and 1 hour 13 min (20) 
Praveen et al. in a prospective randomized 
study found out that median blood loss under 
hypotensive anesthesia was 200 (90-400) ml  
and under normotensive anesthesia was 350 (130-
1575) ml. They justified the use of Hypotensive 
anesthesia in orthognathic surgeries(21). 
Zellin et al. studied thirty patients undergoing 
Lefort I osteotomy. They concluded that blood loss 
during orthognathic surgery under hypotensive 
anesthesia could be significantly reduced when a 
combination of Tranxemic acid and Desmopression 
is added (22). 
Complications following hypotensive anaesthesia 
are postural hypotension, rebound hypertension, 
myocardial ischemia, arrhythmia, delayed awakening, 
impaired cerebral function, neurological deficit, 
hypoxia, reactionary bleeding, hypothermia, and 
lactic acidosis. Enderby reported a mortality of 
<0.01% in his series of 9107 patients.(13) Pasch 
and Huk reported a mortality of 0.06% among 
1802 patients(12). Kerr reported 0% mortality in 
his study (23). However, we did not encounter any 
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complications intraoperatively or postoperatively. 
Studies of Lessard et al. (1) Precious et al. (24) and 
Fahmy(25) have shown no reduction in duration of 
surgery when hypotensive anesthesia was used. 
The advantages in this study was use of a 
noninvasive method to monitor blood pressure, use 
of single drug to induce hypotension, maintaining 
MAP at an average value of 75.18 mm of Hg 
without interfering with other organ systems, 0% 
mortality and morbidity. The added advantage was 
to have a single operator for performing all the 
surgical procedures in our study.  
1. The sample size was relatively small to yield 
appreciable results for individual orthognathic 
surgical procedures. 
2.  As this study involved a small sample size with 
dissimilar groups the values could not be 
averaged leading to marked difference in results.   
Conclusion 
The following inference can be drawn from 
this study: 
1.  Hypotensive anesthesia is a safe method for 
reducing intra operative blood loss and 
operative time. 
2.  Esmolol can be used as a safe and predictable 
drug to induce hypotension during surgery. 
3. Based on Surgeon’s and Anesthetist’s assessment 
fast acting agents like Esmolol can be used 
intraoperative to induce hypotension as and 
when required such as during osteotomy, down 
fractures etc. 
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